About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
249 genotypes with 253 annotations displayed of selected term and subterms
Searched Term: abnormal seizure response to pharmacological agent
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Adamts4tm1Dgen/Adamts4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Adktm2Bois/Adktm2Bois
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		increased susceptibility to pharmacologically induced seizures J:237189
Aifm1Hq/Y
(B6CBACa Aw-J/A-Aifm1Hq/J) 		abnormal seizure response to pharmacological agent J:98103
Aifm1Hq/Aifm1Hq
(B6CBACa Aw-J/A-Aifm1Hq/J) 		abnormal seizure response to pharmacological agent J:98103
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6 * FVB/N) 		decreased susceptibility to pharmacologically induced seizures J:138972
Akt3Nmf350/Akt3+
(C57BL/6J-Akt3Nmf350) 		increased susceptibility to pharmacologically induced seizures J:169028
Akt3Nmf350/Akt3Nmf350
(C57BL/6J-Akt3Nmf350) 		increased susceptibility to pharmacologically induced seizures J:169028
Alg13em1Bayu/Y
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:275180
Amphtm1Pdc/Amphtm1Pdc
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:75306
Ap3m2tm1Ohno/Ap3m2tm1Ohno
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:93312
Arhgap32tm1Taki/Arhgap32tm1Taki
(B6N.Cg-Arhgap32tm1Taki) 		increased susceptibility to pharmacologically induced seizures J:236753
Arxtm3Kki/Y
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:152416
Atp1a3tm1.1Tmklh/Atp1a3+
(B6JRj.129S1-Atp1a3tm1.1Tmklh) 		increased susceptibility to pharmacologically induced seizures J:254463
Atp1a3tm1Ute/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:262419
Atp6v1b2em1Pcamp/Atp6v1b2+
(C57BL/6N-Atp6v1b2em1Pcamp) 		increased susceptibility to pharmacologically induced seizures J:342781
Atp6v1b2em1Pcamp/Atp6v1b2em1Pcamp
(C57BL/6N-Atp6v1b2em1Pcamp) 		increased susceptibility to pharmacologically induced seizures J:342781
Avpr1btm1Dgen/Avpr1btm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Baiap3tm1Smwk/Baiap3tm1Smwk
(B6N.129P2-Baiap3tm1Smwk) 		increased susceptibility to pharmacologically induced seizures J:221234
Bhlhe40tm1.1Rhli/Bhlhe40tm1.1Rhli
(involves: 129S1/Sv * C57BL/6 * CD-1 * SJL) 		increased susceptibility to pharmacologically induced seizures J:131834
Bis1C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
Bis4A/J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
Bsntm1Gund/Bsntm1Gund
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:82241
Cacna1atg/Cacna1atg
(B6.D2-Cacna1atg/J) 		increased susceptibility to pharmacologically induced seizures J:6154
Cacna1gtm1Hssh/Cacna1gtm1Hssh
(involves: 129S4/SvJae * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:70557
Cacna2d2tm1Svi/Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:92396
Cdk5r1tm1Lht/Cdk5r1tm1Lht
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:38857
Cdyltm1.1Yuw/Cdyltm1.1Yuw
Emx1tm1(cre)Yql/Emx1+
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:251551
Chrna4tm1Dra/Chrna4tm1Dra
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:97020
Chrna5tm1Mdb/Chrna5tm1Mdb
(B6.129-Chrna5tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
Chrna5tm1Mdb/Chrna5tm1Mdb
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb Chrna5tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
Chrna7tm1Bay/Chrna7tm1Bay
(B6.Cg-Chrna7tm1Bay) 		abnormal seizure response to pharmacological agent J:74703
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
Cittm1Fdc/Cittm1Fdc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		increased susceptibility to pharmacologically induced seizures J:77297
Ckbtm1Bew/Ckbtm1Bew
(involves: 129P/Ola * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:89399
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:80901
Cln3tm1Blda/Cln3tm1Blda
(B6.129-Cln3tm1Blda) 		increased susceptibility to pharmacologically induced seizures J:125194
Cnr1tm1.1Ltz/Cnr1+
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
Cnr1tm1.1Ltz/Cnr1tm1.1Ltz
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
(involves: 129P2/OlaHsd * C57BL/6NCrl) 		increased susceptibility to pharmacologically induced seizures J:122066
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Neurod6tm1(cre)Kan/Neurod6+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6NCrl) 		increased susceptibility to pharmacologically induced seizures J:122066
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Tg(Camk2a-cre)2Gsc/?
(involves: 129P2/OlaHsd * C57BL/6NCrl * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:122066
Cnr1tm2Ltz/Cnr1tm2Ltz
(B6.Cg-Cnr1tm2Ltz) 		increased susceptibility to pharmacologically induced seizures J:199647
Cntn2tm1Fuka/Cntn2tm1Fuka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:67556
Coq8atm1.1Ics/Coq8atm1.1Ics
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:249129
Cosz1DBA/2J/Cosz1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cosz2DBA/2J/Cosz2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cosz3C57BL/6J/Cosz3C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cosz3C57BL/6J/Cosz3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Emx1tm1(cre)Yql/Emx1+
(B6.129-Emx1tm1(cre)Yql Ctnnb1tm2Kem) 		increased susceptibility to pharmacologically induced seizures J:92923
Cul4btm1Swl/Y
Edil3Tg(Sox2-cre)1Amc/Edil3+
(B6.Cg-Edil3Tg(Sox2-cre)1Amc Cul4btm1Swl) 		increased susceptibility to pharmacologically induced seizures J:187403
Del(7Chrna7-Fan1)3Arte/+
(involves: C57BL/6J * C57BL/6NTac) 		abnormal seizure response to pharmacological agent J:260165
decreased susceptibility to pharmacologically induced seizures J:260165
Depdc5tm1c(EUCOMM)Hmgu/Depdc5tm1c(EUCOMM)Hmgu
Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6N * CBA) 		increased susceptibility to pharmacologically induced seizures J:260943
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:65767
Ecpasem1Plch/Ecpasem1Plch
(C57BL/6-Ecpasem1Plch) 		increased susceptibility to pharmacologically induced seizures J:282974
Efhc1tm1Kzy/Efhc1+
(B6.129P2-Efhc1tm1Kzy) 		increased susceptibility to pharmacologically induced seizures J:145858
Efhc1tm1Kzy/Efhc1tm1Kzy
(B6.129P2-Efhc1tm1Kzy) 		increased susceptibility to pharmacologically induced seizures J:145858
Elfn1tm1.1Jaru/Elfn1tm1.1Jaru
(involves: C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:226212
Elfn2tm1(KOMP)Vlcg/Elfn2tm1(KOMP)Vlcg
(C57BL/6NTac-Elfn2tm1(KOMP)Vlcg) 		increased susceptibility to pharmacologically induced seizures J:286127
Eml1heco/Eml1heco
(involves: NOR) 		increased susceptibility to pharmacologically induced seizures J:208031
Emx1tm1.1(cre)Ito/Emx1+
Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:139349
Exq1A/J/?
(involves: A/J * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:54925
Exq1C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
Faim2tm1Dgen/Faim2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Fgf7tm1Efu/Fgf7tm1Efu
(B6.129-Fgf7tm1Efu) 		increased susceptibility to pharmacologically induced seizures J:161954
Fgf14tm1Dor/Fgf14tm1Dor
(129S6/SvEvTac-Fgf14tm1Dor) 		increased susceptibility to pharmacologically induced seizures J:77806
Fgf14tm1Dor/Fgf14tm1Dor
(B6.129S6-Fgf14tm1Dor) 		increased susceptibility to pharmacologically induced seizures J:77806
Fgf22tm1Dgen/Fgf22tm1Dgen
(B6.Cg-Fgf22tm1Dgen) 		decreased susceptibility to pharmacologically induced seizures J:161954
Fzd9tm1Sjp/Fzd9tm1Sjp
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:99893
Gabra1tm1.1Geh/Gabra1+
(B6.129(Cg)-Gabra1tm1.1Geh) 		increased susceptibility to pharmacologically induced seizures J:227437
Gabra1tm1.1Mjga/Gabra1+
(B6J.Cg-Gabra1tm1.1Mjga) 		increased susceptibility to pharmacologically induced seizures J:227437
Gabra1tm1.1Uru/Gabra1tm1.1Uru
(either: 129X1.129P2-Gabra1tm1.1Uru or B6.129P2-Gabra1tm1.1Uru) 		increased susceptibility to pharmacologically induced seizures J:75895
Gabrb3tm2.1Uru/Gabrb3tm2.1Uru
(B6J.129S6(Cg)-Gabrb3tm2.1Uru) 		increased susceptibility to pharmacologically induced seizures J:228332
Gabrdtm1.1Jmag/Gabrd+
Gad2tm2(cre)Zjh/Gad2+
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased susceptibility to pharmacologically induced seizures J:203336
Gabrg2tm1.2Rmac/Gabrg2+
(involves: C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:306976
Gabrg2tm1Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:127120
Gabrg2tm1Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		increased susceptibility to pharmacologically induced seizures J:194736
Gabrg2tm2Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to pharmacologically induced seizures J:194196
Gabrg2tm2Spet/Gabrg2+
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:194736
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn) 		increased susceptibility to pharmacologically induced seizures J:77625
Gdi1tm1Ytk/Gdi1tm1Ytk
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * C57BL/6 * DBA/2)) 		increased susceptibility to pharmacologically induced seizures J:65258
Gfaptm2Mes/Gfap+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:114689
Glra1tm1.1Geh/Glra1tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:177105
Glra1tm2.1Geh/Glra1tm2.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:177106
Glra3tm1Dgen/Glra3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Gria3tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
Gria4tm1Dgen/Gria4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal seizure response to pharmacological agent J:101679
Grik2tm1Bvis/Grik2tm1Bvis
(129S/Sv-Grik2tm1Bvis) 		increased susceptibility to pharmacologically induced seizures J:107698
Grik2tm1Sfh/Grik2tm1Sfh
(involves: 129S1/Sv * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:46932
Grik4tm1(cre)Mim/Grik4+
Grin1tm1Mim/Grin1tm1Mim
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:144994
Grik5tm1Dgen/Grik5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Grin1tm1Blt/Grin1tm1Blt
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:62289
Grm5tm1Dgen/Grm5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:82809
increased susceptibility to pharmacologically induced seizures J:82809
Grm7tm1Betz/Grm7tm1Betz
(B6.129P2-Grm7tm1Betz) 		increased susceptibility to pharmacologically induced seizures J:138831
Grm7tm1Dgen/Grm7tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Gsg1ltm1.2Tern/Gsg1ltm1.2Tern
(C57BL/6J-Gsg1ltm1.2Tern) 		increased susceptibility to pharmacologically induced seizures J:301313
Gt(ROSA)26Sortm1(Crh)Jde/Gt(ROSA)26Sortm1(Crh)Jde
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		abnormal seizure response to pharmacological agent J:140968
Hcn2ap/Hcn2+
(DW/Pas-Hcn2ap) 		increased susceptibility to pharmacologically induced seizures J:146530
Hcrtr1tm1Dgen/Hcrtr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Hprt1tm1(CAG-Glra3*)Jcme/Y
Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:207981
Htr1atm1Toth/Htr1atm1Toth
(involves: 129P2/OlaHsd * Black Swiss) 		increased susceptibility to pharmacologically induced seizures J:66581
Htr2ctm1Jul/Y
(either: (involves: 129S2/SvPas * C57BL/6J * DBA/2) or (involves: 129S4/SvJae * C57BL/6J * DBA/2)) 		increased susceptibility to pharmacologically induced seizures J:24339
Htr4tm1Comp/Htr4tm1Comp
(129/Sv-Htr4tm1Comp) 		increased susceptibility to pharmacologically induced seizures J:87451
Htr7tm1Wtkn/Htr7tm1Wtkn
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased susceptibility to pharmacologically induced seizures J:124549
Igsf9tm1Kln/Igsf9tm1Kln
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:209586
Impa1tm1Lex/Impa1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:157887
Iqsec2em1Frk/Y
(involves: C3HeB/FeJ * C57BL/6NJ) 		decreased susceptibility to pharmacologically induced seizures J:284762
Juntm2.1Wag/Juntm2.1Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:53481
Kcna1tm1Tem/Kcna1+
(involves: 129S7/SvEvBrd * various) 		increased susceptibility to pharmacologically induced seizures J:47349
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * various) 		increased susceptibility to pharmacologically induced seizures J:47349
Kcna2tm1Tem/Kcna2+
(C3Fe.129S7-Kcna2tm1Tem) 		increased susceptibility to pharmacologically induced seizures J:131735
Kcna2tm1Tem/Kcna2tm1Tem
(C3Fe.129S7-Kcna2tm1Tem) 		increased susceptibility to pharmacologically induced seizures J:131735
Kcnc2tm1Rudy/Kcnc2tm1Rudy
(B6.129S1-Kcnc2tm1Rudy) 		increased susceptibility to pharmacologically induced seizures J:66730
Kcnh3tm1.2Tije/Kcnh3tm1.2Tije
(involves: C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:165296
Kcnip1tm1Zhzh/Kcnip1tm1Zhzh
(involves: C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:227383
Kcnj6tm1Stf/Kcnj6tm1Stf
(involves: 129S1/Sv * 129X1/SvJ) 		increased susceptibility to pharmacologically induced seizures J:38206
Kcnk2tm1Lzd/Kcnk2tm1Lzd
(involves: 129 * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:91531
Kcnq2Nmf134/Kcnq2+
(C57BL/6J-Kcnq2Nmf134) 		increased susceptibility to pharmacologically induced seizures J:136510
Kcnq2tm1Dgen/Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Kcnq2tm1Hsa/Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:62797
Kcnt1em1Lekk/Kcnt1+
(C57BL/6J-Kcnt1em1Lekk) 		increased susceptibility to pharmacologically induced seizures J:287751
Kdm1atm1Ebg/Kdm1atm1Ebg
(B6.129-Kdm1atm1Ebg) 		decreased susceptibility to pharmacologically induced seizures J:235553
Kif4em1Noh/Y
(C57BL/6J-Kif4em1Noh) 		increased susceptibility to pharmacologically induced seizures J:336792
Klk8tm1Lth/Klk8tm1Lth
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:71533
L2hgdhGt(DC0625)Wtsi/L2hgdhGt(DC0625)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:228407
Lamp5em1Lmit/Lamp5+
(C57BL/6-Lamp5em1Lmit) 		increased susceptibility to pharmacologically induced seizures J:345459
Lamp5em1Lmit/Lamp5em1Lmit
(C57BL/6-Lamp5em1Lmit) 		increased susceptibility to pharmacologically induced seizures J:345459
Letm1Gt(CC0204)Wtsi/Letm1+
(129S.129P2-Letm1Gt(CC0204)Wtsi) 		increased susceptibility to pharmacologically induced seizures J:222017
Letm1Gt(DD0926)Wtsi/Letm1+
(129S.129P2-Letm1Gt(DD0926)Wtsi) 		increased susceptibility to pharmacologically induced seizures J:222017
Lgi1tm1Mafu/Lgi1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:157578
Lhx6tm1Vpa/Lhx6tm2Vpa
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:198547
Lrrc4btm1Lex/Lrrc4btm1Lex
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:276446
Mapk10tm1Flv/Mapk10tm1Flv
(involves: 129S1/Sv) 		decreased susceptibility to pharmacologically induced seizures J:43658
Mapttm1Hnd/Mapt+
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mapttm1Hnd/Mapt+
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mapttm1Hnd/Mapttm1Hnd
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mapttm1Hnd/Mapttm1Hnd
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mbnl2tm1.1Sws/Mbnl2+
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:218010
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:218010
Mbpshi/Mbpshi
Tg(Thy1-YFP)HJrs/0
(involves: C3HeB/Fe * C57BL/6 * CBA * SWV) 		increased susceptibility to pharmacologically induced seizures J:158545
Mc2rtm1Dgen/Mc2rtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82809
Mecp2tm3Meg/Y
(B6.129-Mecp2tm3Meg) 		increased susceptibility to pharmacologically induced seizures J:204723
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J) 		increased susceptibility to pharmacologically induced seizures J:89429
Mt3tm1Rpa/Mt3tm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:38222
n-TRtct5m1J/n-TRtct5m1J
(C57BL/6J) 		abnormal seizure response to pharmacological agent J:297745
n-TRtct5tm1.1Slac/n-TRtct5tm1.1Slac
(C57BL/6J-n-TRtct5tm1.1Slac) 		abnormal seizure response to pharmacological agent J:297745
n-TRtct5tm2.1Slac/n-TRtct5tm2.1Slac
(C57BL/6NJ-n-TRtct5tm2.1Slac) 		abnormal seizure response to pharmacological agent J:297745
Neurod2tm1Tap/Neurod2tm1Tap
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:69606
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		increased susceptibility to pharmacologically induced seizures J:218959
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal seizure response to pharmacological agent J:210491
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
Gys1tm1c(EUCOMM)Wtsi/Gys1+
Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac) 		abnormal seizure response to pharmacological agent J:210491
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
Gys1tm1c(EUCOMM)Wtsi/Gys1tm1c(EUCOMM)Wtsi
Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac) 		abnormal seizure response to pharmacological agent J:210491
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau) 		increased susceptibility to pharmacologically induced seizures J:107300
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:124729
Npytm1Rpa/Npytm1Rpa
(involves: 129S7/SvEvBrd) 		increased susceptibility to pharmacologically induced seizures J:33261
Npytm2Rpa/Npytm2Rpa
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:104699
Nr4a3tm1Omc/Nr4a3tm1Omc
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:93320
Nrp2tm1.2Mom/Nrp2+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ) 		increased susceptibility to pharmacologically induced seizures J:166116
Nrp2tm1.2Mom/Nrp2tm1.2Mom
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ) 		increased susceptibility to pharmacologically induced seizures J:166116
Oprd1tm1Dgen/Oprd1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
P2rx6tm1Dgen/P2rx6tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:82809
Panx1tm1.1Fama/Panx1tm1.1Fama
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:177671
Panx1tm1a(KOMP)Wtsi/Panx1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased susceptibility to pharmacologically induced seizures J:177671
Pcmt1tm1Scl/Pcmt1tm1Scl
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:40967
Pde8atm1Dgen/Pde8atm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82809
Pdyntm1(cre)Czer/Pdyn+
(B6.Cg-Pdyntm1(cre)Czer) 		increased susceptibility to pharmacologically induced seizures J:122651
Pdyntm1(cre)Czer/Pdyntm1(cre)Czer
(B6.Cg-Pdyntm1(cre)Czer) 		increased susceptibility to pharmacologically induced seizures J:122651
Phf6em1Azbi/Y
(B6.Cg-Phf6em1Azbi) 		increased susceptibility to pharmacologically induced seizures J:271089
Pis1A/J/Pis1A/J
(C57BL/6J-Chr 10A/J/NaJ) 		increased susceptibility to pharmacologically induced seizures J:118211
Pis2A/J/Pis2A/J
(C57BL/6J-Chr 18A/J/NaJ) 		increased susceptibility to pharmacologically induced seizures J:118211
Plaurtm1Mlg/Plaurtm1Mlg
(B6.Cg-Plaurtm1Mlg) 		increased susceptibility to pharmacologically induced seizures J:81735
Plcb1tm1Hssh/Plcb1tm1Hssh
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:43077
Plcl1tm1Mh/Plcl1tm1Mh
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:92956
Plppr5em2Gpt/Plppr5em2Gpt
(C57BL/6-Plppr5em2Gpt) 		increased susceptibility to pharmacologically induced seizures J:324004
Ppp1r9btm1Jfe/Ppp1r9btm1Jfe
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:77284
Prickle1em1Yzou/Prickle1+
(C57BL/6-Prickle1em1Yzou) 		increased susceptibility to pharmacologically induced seizures J:321396
Prickle2tm1Nue/Prickle2tm1Nue
(B6.Cg-Prickle2tm1Nue) 		increased susceptibility to pharmacologically induced seizures J:169136
Prrt2tm1a(KOMP)Wtsi/Prrt2tm1a(KOMP)Wtsi
(C57BL/6N-Atm1Brd Prrt2tm1a(KOMP)Wtsi/Wtsi) 		increased susceptibility to pharmacologically induced seizures J:237823
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac) 		increased susceptibility to pharmacologically induced seizures J:141610
Ptprotm1Dgen/Ptprotm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Rbfox1tm1.1Dblk/Rbfox1+
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:176189
Rbfox1tm1.1Dblk/Rbfox1tm1.1Dblk
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:176189
Rbfox3tm1a(EUCOMM)Hmgu/Rbfox3tm1a(EUCOMM)Hmgu
(B6Dnk;B6N-Rbfox3tm1a(EUCOMM)Hmgu/H) 		increased susceptibility to pharmacologically induced seizures J:234043
Rogditm1.2Ics/Rogditm1.2Ics
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:344072
Ryr2tm1Slh/Ryr2+
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:235432
Ryr2tm2Amks/Ryr2+
(B6.129-Ryr2tm2Amks) 		increased susceptibility to pharmacologically induced seizures J:137696
Ryr2tm2Amks/Ryr2tm2Amks
(B6.129-Ryr2tm2Amks) 		increased susceptibility to pharmacologically induced seizures J:137696
Scn1aem1Anord/Scn1a+
(C57BL/6N-Scn1aem1Anord) 		increased susceptibility to pharmacologically induced seizures J:333350
Scn1atm1.1Aesc/Scn1a+
(involves: 129X1/SvJ * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:161191
Scn1atm1.1Aesc/Scn1a+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:170734
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:209093
Scn1atm1Wac/Scn1a+
(involves: 129S1/Sv * 129X1/SvJ * FVB/NJ) 		increased susceptibility to pharmacologically induced seizures J:129998
Scn2btm1Isom/Scn2btm1Isom
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82050
Scn8amed-jo/Scn8a+
(B6.D2-Scn8amed-jo/J) 		decreased susceptibility to pharmacologically induced seizures J:170734, J:129998
Scn8amed/Scn8a+
(C3Fe.Cg-Scn8amed/J) 		decreased susceptibility to pharmacologically induced seizures J:129998
Serpine2tm1Dmn/Serpine2tm1Dmn
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:40953
Sez6tm1.1Sest/Sez6tm1.1Sest
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:132725
Shank3tm1.1Cya/Shank3tm1.1Cya
(B6.Cg-Shank3tm1.1Cya) 		decreased susceptibility to pharmacologically induced seizures J:281328
Sicd1C57BL/6J/Sicd1C57BL/6J
(FVB.B6-(D18Mit141-D18Mit25)) 		increased susceptibility to pharmacologically induced seizures J:122922
Sipa1l1tm1Taki/Sipa1l1tm1Taki
(B6.Cg-Sipa1l1tm1Taki/Taki) 		increased susceptibility to pharmacologically induced seizures J:345320
Slc1a2tm1Kta/Slc1a2tm1Kta
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:40984
Slc1a3tm1Kta/Slc1a3tm1Kta
(involves: 129P2/OlaHsd) 		increased susceptibility to pharmacologically induced seizures J:58180
Slc4a3tm1Cahb/Slc4a3tm1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:104157
Slc4a10tm1.1Cahb/Slc4a10tm1.1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:131058
Slc6a11tm1Dgen/Slc6a11+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
Slc7a8tm1Dgen/Slc7a8tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
Slc9a6tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Slc10a4tm1Tigm/Slc10a4tm1Tigm
(involves: 129S/SvEvBrd) 		increased susceptibility to pharmacologically induced seizures J:196996
Slc12a5tm1Dlp/Slc12a5+
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:113307
Slc12a5tm1Hsav/Slc12a5tm2Hsav
(involves: 129S1/Sv * 129S2/SvPasHsd * 129X1/SvJ * C57BL/6J * C57BL/6JOlaHsd) 		increased susceptibility to pharmacologically induced seizures J:101079
Slc12a6tm1Tjj/Slc12a6tm1Tjj
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:86183
Slc18a3tm1Mca/Slc18a3tm1Mca
(involves: 129S4/SvJae * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:136620
Slitrk3tm1Jaru/Slitrk3tm1Jaru
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:232385
Stamtm1Sug/Stamtm1Sug
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:69504
Syngap1tm1Rlh/Syngap1+
(involves: 129S1/Sv * 129X1/SvJ) 		increased susceptibility to pharmacologically induced seizures J:193208
Szs1C57BL/6J/Szs1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
Szs1DBA/2J/Szs1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
Szs5DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
Szs6C57BL/6J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
Szt1/Szt1+
(involves: BALB/cByJ * BALB/cJ * C57BL/6J) 		abnormal seizure response to pharmacological agent J:82964
Szt2m1Frk/Szt2m1Frk
(involves: BALB/cByJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:150942
Szv1C57BL/6J/Szv1C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
Szv2C57BL/6J/Szv2C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
Szv2C57BL/6J/Szv2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
Szv3C57BL/6J/Szv3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:70295
Szv3DBA/2J/Szv3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:70295
Tg(Camk2a-Fyn-531)1Nko/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		increased susceptibility to pharmacologically induced seizures J:59490
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-MAPT)32Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT)32Lms) 		increased susceptibility to pharmacologically induced seizures J:233816
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-MAPT*A152T)L1Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT*A152T)L1Lms) 		increased susceptibility to pharmacologically induced seizures J:233816
Tg(DBH-Gal)1923Stei/0
(B6.Cg-Tg(DBH-Gal)1923Stei) 		decreased susceptibility to pharmacologically induced seizures J:77625
Tg(GFAP-EFNA3)181Kln/0
(involves: C57BL/6 * FVB) 		increased susceptibility to pharmacologically induced seizures J:154648
Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:139349
Tg(Lgi1*)#Mpan/0
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:154129
Tg(Lmnb1)1Yfu/0
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:197168
Tg(Plp1-HTT*150Q)4aXjl/0
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:221608
Tg(Prnp-lacZ/ATXN10*)#Teas/0
(involves: FVB/N) 		increased susceptibility to pharmacologically induced seizures J:222081
Tg(Scn1a*)RH9Aesc/0
(involves: FVB/NJ) 		increased susceptibility to pharmacologically induced seizures J:150454
Tg(Thy1-App*R609D*K612E)4Vln/Tg(Thy1-App*R609D*K612E)4Vln
(involves: FVB) 		decreased susceptibility to pharmacologically induced seizures J:32213
increased susceptibility to pharmacologically induced seizures J:32213
Tg(Thy1-App*R609D*K612E)6Vln/Tg(Thy1-App*R609D*K612E)6Vln
(involves: FVB) 		decreased susceptibility to pharmacologically induced seizures J:32213
increased susceptibility to pharmacologically induced seizures J:32213
Tg(Thy1-MAPT*)1Avil/Tg(Thy1-MAPT*)1Avil
(involves: C57BL/6 * CBA) 		increased susceptibility to pharmacologically induced seizures J:201700
Tg(Thy1-SERPINI1*G392E)333Icka/0
(involves: C57BL * CD-1 * DBA) 		increased susceptibility to pharmacologically induced seizures J:144649
Tg(Thy1-SERPINI1*G392E)333Icka/Tg(Thy1-SERPINI1*G392E)333Icka
(involves: C57BL * CD-1 * DBA) 		increased susceptibility to pharmacologically induced seizures J:144649
Tg(UBC-Adk)1Bois/0
(B6;129P3-Adktm1Bois Tg(UBC-Adk)1Bois) 		abnormal seizure response to pharmacological agent J:105483
tmgc61/tmgc61
(Mixed stock) 		decreased susceptibility to pharmacologically induced seizures J:92490
Trim3tm1Mak/Trim3tm1Mak
(B6.129P2-Trim3tm1Mak) 		decreased susceptibility to pharmacologically induced seizures J:161372
Trpc5tm1.1Lbi/Y
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:194590
Trpc5tm1.1Lbi/Trpc5tm1.1Lbi
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:194590
Tubg1tm1.1Ics/Tubg1+
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:275532
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: C57BL/6 * DBA/2) 		increased susceptibility to pharmacologically induced seizures J:121330
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory